Balance Sheet
Cash Flow Statement
AcquisitionsAmortization of Deferred ChargesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)DivestmentsDividends Paid - CommonFree Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based CompensationShort-Term Debt issuances
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Select Medical Holdings (SEM) Deferred Taxes (2018 - 2025)

Select Medical Holdings (SEM) has disclosed Deferred Taxes for 7 consecutive years, with $20.1 million as the latest value for Q4 2025.

  • On a quarterly basis, Deferred Taxes rose 701.95% to $20.1 million in Q4 2025 year-over-year; TTM through Dec 2025 was $30.7 million, a 194.51% increase, with the full-year FY2025 number at $30.7 million, up 194.51% from a year prior.
  • Deferred Taxes was $20.1 million for Q4 2025 at Select Medical Holdings, up from $17.9 million in the prior quarter.
  • In the past five years, Deferred Taxes ranged from a high of $20.1 million in Q4 2025 to a low of -$27.4 million in Q2 2024.
  • A 5-year average of -$266250.0 and a median of -$2.0 million in 2022 define the central range for Deferred Taxes.
  • Peak YoY movement for Deferred Taxes: soared 10804.4% in 2021, then crashed 719.29% in 2023.
  • Select Medical Holdings' Deferred Taxes stood at $17.0 million in 2021, then decreased by 14.21% to $14.6 million in 2022, then plummeted by 93.63% to $930000.0 in 2023, then skyrocketed by 169.57% to $2.5 million in 2024, then surged by 701.95% to $20.1 million in 2025.
  • Per Business Quant, the three most recent readings for SEM's Deferred Taxes are $20.1 million (Q4 2025), $17.9 million (Q3 2025), and -$1.7 million (Q2 2025).